Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 5, 2009, Pages 806-814

  Kim, Kang Mo ^b   Kim, Jong Hoon ^b   Park, Ik Soo ^b   Ko, Gi Young ^c   Yoon, Hyun Ki ^c   Sung, Kyu Bo ^c   Lim, Young Suk ^b   Lee, Han Chu ^b   Chung, Young Hwa ^b   Lee, Yung Sang ^b   Suh, Dong Jin ^a,b  

^a Asan Medical Center   (South Korea)

^b Department of Internal Medicine ^*

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Portal vein invasion; Radiation therapy; Survival analysis; Transarterial chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PORTAL VEIN; PRIORITY JOURNAL; SAFETY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PORTAL VEIN; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65949105956     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05728.x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001 94 : 153 6. (Pubitemid 32911406)
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999 340 : 745 50. (Pubitemid 29114292)
3. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002 35 : 519 24. (Pubitemid 34183954)
4. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001 35 : 421 30.
5. Bruix J, Sherman M, Guidelines P. Committee American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 36.
6. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999 19 : 329 38. (Pubitemid 29488775)
7. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 : 1164 71. (Pubitemid 34454013)
8. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 359 : 1734 9. (Pubitemid 34607087)
9. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003 37 : 429 42. (Pubitemid 36152543)
10. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J. Gastroenterol. 2005 40 : 225 35. (Pubitemid 40613379)
11. Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs 2004 15 : 439 52. (Pubitemid 38736941)
12. Abou-Alfa GK, Schwartz L, Ricci S et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J. Clin. Oncol. 2006 24 : 4293 300. (Pubitemid 46630787)
13. Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987 7 : 952 63. (Pubitemid 17139246)
14. Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis. J. Vasc. Interv. Radiol. 1993 4 : 347 51.
15. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997 79 : 2087 94. (Pubitemid 27227372)
16. Tazawa J, Maeda M, Sakai Y et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J. Gastroenterol. Hepatol. 2001 16 : 660 5. (Pubitemid 34188841)
17. Zeng ZC, Fan J, Tang ZY et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int. J. Radiat. Oncol. Biol. Phys. 2005 61 : 432 43. (Pubitemid 40164438)
18. Ishikura S, Ogino T, Furuse J et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am. J. Clin. Oncol. 2002 25 : 189 93. (Pubitemid 34293077)
19. Takayasu K, Arii S, Ikai I et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006 131 : 461 9. (Pubitemid 44142456)
20. Kasugai H, Kojima J, Tatsuta M et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989 97 : 965 71. (Pubitemid 19239037)
21. Allison DJ, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet 1985 1 : 595 9. (Pubitemid 15133881)
22. Bismuth H, Morino M, Sherlock D et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am. J. Surg. 1992 163 : 387 94. (Pubitemid 23065050)
23. Yen FS, Wu JC, Kuo BI, Chiang JH, Chen TZ, Lee SD. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis. J. Gastroenterol. Hepatol. 1995 10 : 237 40.
24. Ishikawa T, Ichida T, Sugitani S et al. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2001 16 : 452 9. (Pubitemid 32397659)
25. Ando E, Tanaka M, Yamashita F et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002 95 : 588 95.
26. Chung YH, Song IH, Song BC et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000 88 : 1986 91. (Pubitemid 30233198)
27. Obi S, Yoshida H, Toune R et al. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006 106 : 1990 7. (Pubitemid 43673215)
28. Raoul JL, Guyader D, Bretagne JF et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J. Nucl. Med. 1994 35 : 1782 7. (Pubitemid 24346799)
29. Llovet JM, Bustamante J, Castells A et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999 29 : 62 7. (Pubitemid 29023987)
30. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N. Engl. J. Med. 1995 332 : 1256 61.
31. Sakata H, Konishi M, Ryu M et al. Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus. Hepatogastroenterology 2004 51 : 1575 80. (Pubitemid 39403004)
32. Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 2006 106 : 1653 63.